High Yield Corp Bond Ishares Iboxx $ ETF (HYG)

$78.17 0.19 (0.24%)

11:44 EDT HYG Stock Quote Delayed 30 Minutes

What You Should Do as High-Yield ETFs Run Hot

By David Fabian, FMD Capital Management Feb 21, 2017

As high-yield ETFs run hot, it’s a great time to evaluate your exposure and consider changes in light of your risk tolerance.

Is the Market Heading Toward a Correction?

7 High-Yield Dividend ETFs to Gamble On

3 High-Yield ETFs That Must Be on Your Radar

Volume:

Previous Close -

Market Cap 171.66M

PE Ratio -

EPS -

Volume (Avg. Vol.) 11.39M

Day's Range $78.11 - $78.26

52-Week Range $71.68 - $78.33

Dividend & Yield $4.21 (5.39%)

HYG Stock Predictions, Articles, and High Yield Corp Bond Ishares Iboxx $ ETF News

3 High-Yield Junk Bonds That AREN’T Junk

By Lawrence Meyers, InvestorPlace Contributor Mar 31, 2016

Junk bonds may have bottomed out, offering a chance to get into ETFs like JNK, HYLD and HYG at a reasonable price.

10 Stocks to Buy for Your Rollover IRA

By Charles Sizemore, Chief Investment Strategist, The Freeport Society Mar 16, 2016

You've rolled your 401k plan into a rollover IRA. Now, here are 10 stocks to buy that can take the most advantage of that IRA's benefits.

iShares iBoxx $ High Yid Corp Bond (ETF): Too Far, Too Fast

By Tim Biggam, InvestorPlace Contributor Mar 9, 2016

Junk bonds (HYG) have seen a strong rally on the back of strong oil. With the rally in oil tempering, junk bonds may as well.

Stocks Stumble to End February in the Red

By Anthony Mirhaydari, InvestorPlace Market Strategist Feb 29, 2016

Defensive utilities led the way while healthcare lagged behind. Elsewhere, Asian markets disappointed overnight after a weekend meeting of G20 leaders ended without any commitment to coordinate new stimulus efforts.

The High-Yield HYG Is Your Rally Vehicle

By Serge Berger, InvestorPlace Contributor Jan 27, 2016

Unlike stocks, the iShares iBoxx $ High Yid Corp Bond (ETF) (HYG) has been falling since 2013. But a major oversold rally is in the cards.

The Market’s Spectacular Bungee Jump

By Richard Band Jan 18, 2016

It's been a rough ride for the S&P 500 do far this year. Here's what to expect and how to invest on the news

S&P 500 (SPY): Here Comes a Volatile 2016!

By Serge Berger, InvestorPlace Contributor Dec 31, 2015

A late cyclical bull market combined with peak jobs data will likely usher in an even rockier road in 2016 for the S&P 500 (SPY).

How to Cut Your Trading Costs in Half

By Dec 15, 2015

Here are four tips to help you save money and add value to your ETF portfolio by cutting costs and expenses

Don’t Listen to Junk Bonds’ 6% Siren Song! (JNK, HYG)

By James Brumley, InvestorPlace Feature Writer Dec 14, 2015

Junk bonds, and junk bond funds, acted like last Friday was a capitulation. But there's plenty more where that came from.

Stocks Suffer on Credit, Crude Oil Carnage

By Anthony Mirhaydari, InvestorPlace Market Strategist Dec 11, 2015

The precipitous drop in the markets follows last week's spectacular gain for the largest single-day decline since September.

Why The U.S. Stock Market Has Never Completely Recovered

By Nov 14, 2015

The S&P 500 rallied 13% off its closing lows in late August. Lost in the shuffle? It hasn't really recovered. Here's why...

Markets Back In Familiar Territory

By Richard Band Nov 4, 2015

Despite continued problems in China and slow economic news, markets continue to roll along, headed back towards a record high

This Indicator Says Don’t Bail Out of the Market Too Soon

By Richard Band Oct 14, 2015

Tuesday's market pullback isn't a sign for investors to take out their money. In fact, one indicator suggests investors stay invested

Time for Markets to Rally On — Maybe (ABBV, JNJ, MCD)

By Richard Band Oct 7, 2015

Several recent rallies in the markets have investors seeing positive signs moving forward, although doubts remain. Here is where I stand.

Wall Street Hit as the Dow Jones Tests 16,000

By Anthony Mirhaydari, InvestorPlace Market Strategist Sep 28, 2015

Stocks are still in the midst of their "hike or no hike" anxiety attack, while the weakness is backed up by government action against Big Pharma and disappointing economic data from China, sending the Dow Jones lower.